Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    "pantothenate kinase-associated neurodegeneration" OR "Hallervorden-Spatz Syndrome"
Show Display Options
Rank Status Study
1 Completed A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Placebo oral solution
2 Active, not recruiting Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: Deferiprone oral solution;   Drug: Deferiprone
3 Recruiting Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-associated Neurodegeneration (PKAN)
Intervention:
4 Available Compassionate Use of Deferiprone in Patients With PKAN
Condition: Pantothenate Kinase-Associated Neurodegeneration
Intervention: Drug: Deferiprone
5 Not yet recruiting Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients
Condition: Pantothenate Kinase-Associated Neurodegeneration
Interventions: Drug: fosmetpantotenate (RE-024);   Drug: Placebo
6 Recruiting NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
Condition: Neurodegeneration With Brain Iron Accumulation (NBIA)
Intervention:
7 Active, not recruiting Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
Conditions: Neurodegenerative Disease;   Iron Overload
Intervention: Drug: Deferiprone

Study has passed its completion date and status has not been verified in more than two years.